Insights from 2024 ESGO Annual Meeting


 

ESGO 2024 Insights: "The Movie Trial - Safety & Efficacy of Durvalumab + Tremelimumab + Metronomic Oral Vinorelbine in Pts With Recurrent/Metastatic Cervical Cancer"

0 views
March 19, 2024
Comments 0
Login to view comments. Click here to Login